Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism-Reference-Cited by-同舟云学术

Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism

Published:2018-01-27 Issue:2 Volume:19 Page:382
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Nepstad Ina^ORCID,Reikvam Håkon,Brenner Annette,Bruserud Øystein,Hatfield Kimberley

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/2/382/pdf

Reference57 articles.

1. Acute Myeloid Leukemia

2. Genomic Classification and Prognosis in Acute Myeloid Leukemia

3. The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells

4. The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients;Martelli;Oncotarget,2010

5. The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AKT inhibition interferes with the expression of immune checkpoint proteins and increases NK-induced killing of HL60-AML cells;einstein (São Paulo);2023

2. Engaging of the mTOR signaling pathway by miR100 and miR101 in de novo acute myeloid leukemia;2022-11-16

3. Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia;Frontiers in Genetics;2022-09-30

4. Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia;Journal of Oncology;2022-08-30

5. The Effects of PI3K/Akt/mTOR Signaling Pathway Inhibitors on the Expression of Immune Checkpoint Ligands in Acute Myeloid Leukemia Cell Line;Iranian Journal of Allergy, Asthma and Immunology;2022-04-17